Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone 25 mg in essential hypertension
2016-001809-16Phase 3Completed
- Sponsor
- Uni-Pharma
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of chlorthalidone in essential hypertension, sponsored by Uni-Pharma. Primary endpoint: Office blood pressure assessment at 4 weeks. Started Jul 2016; status: completed.
02
Drugs
chlorthalidone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2016-001809-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001809-16.